Commercial

Commercial  ·  T cell targeting therapies
TScan Therapeutics announced $100 M Series C financing

T cell targeting therapies – January 2021 T cell targeting therapies – January 2021 TScan Therapeutics announced $100 million Series C financing managed by BlackRock and RA Capital 25 Jan 2021 TScan Therapeutics – TSC-100 and TSC-101 (TCR-T cell therapy) […]

by Sandhya Ramalingam

Continue Reading
Commercial  ·  T cell targeting therapies
Collaborations worth $2.6+ billion executed in T cell engager platforms in the last one month

T cell targeting therapies – January 2021 T cell targeting therapies – January 2021 Janux Therapeutics announced a collaboration with Merck to develop novel drug candidates for immuno-oncology using T cell engager (TRACTr) technology 18 Dec 2020 Janux Therapeutics/Merck – […]

by Sandhya Ramalingam

Continue Reading